Articles related to Oncology, Surgical

Discover how mechanoresilient cancer cells evade the body’s natural defenses and what this means for the future of targeted cancer therapies.

New research indicates that PCI offers significant survival advantages over TRT in treating extensive-stage small cell lung cancer, challenging existing treatment protocols.

The recent phase 3 trial on 177Lu-PSMA-617 offers compelling evidence for its efficacy in extending survival rates for advanced prostate cancer patients. Could this therapy eventually become an addition to your treatment arsenal?

The proposed changes to the 2024 MPFS could have far-reaching implications for oncology care; stay informed to understand how these changes may impact your practice and patient outcomes.

The recent Stark Law interpretation has disrupted established medication delivery systems, posing a significant challenge for oncology practices. Learn how healthcare professionals are advocating for change and what alternative solutions are being explored.

Recent findings from the MARS 2 trial challenge traditional treatment protocols for mesothelioma, indicating that chemotherapy alone may offer improved outcomes over combined surgical approaches. Discover why experts are re-evaluating long-standing surgical treatments.